XML 50 R35.htm IDEA: XBRL DOCUMENT v3.7.0.1
Basis of Presentation, Organization and Business and Summary of Significant Accounting Policies (Details Narrative)
1 Months Ended 3 Months Ended 12 Months Ended
May 10, 2010
USD ($)
Dec. 31, 2016
shares
Jun. 30, 2017
USD ($)
Mar. 31, 2017
USD ($)
Dec. 31, 2016
USD ($)
Sep. 30, 2016
USD ($)
Jun. 30, 2016
USD ($)
Mar. 31, 2016
USD ($)
Dec. 31, 2015
USD ($)
Sep. 30, 2015
USD ($)
Jun. 30, 2017
USD ($)
Segment
shares
Jun. 30, 2016
USD ($)
shares
Jun. 30, 2015
USD ($)
shares
Jul. 01, 2017
USD ($)
Ownership percentage     100.00%               100.00%      
Number of operating segment | Segment                     1      
Cash and cash equivalents     $ 11,557,071               $ 11,557,071      
Cash held uninsured amount     11,325,285               11,325,285      
Sales from continuing operations     7,890,195 $ 7,177,763 $ 6,030,380 $ 6,171,625 $ 6,396,707 $ 5,426,147 $ 6,039,355 $ 5,250,985 27,269,963 $ 23,113,194 $ 22,204,578  
Finite lived intangible assets, net     719,136       604,916       $ 719,136 $ 604,916    
Excluded from the calculation of diluted EPS | shares                     1,191,236 1,790,224 257,000  
Advertising expense                     $ 76,000 $ 386,000 $ 155,000  
Restricted Stock [Member]                            
Excluded from the calculation of diluted EPS | shares   400,000                        
Generators [Member]                            
Estimated useful lives                       P3Y    
Depreciation expense                     425,000 $ 416,000 232,000  
Impact of change in accounting estimate reduction in expenses                     283,000      
Net Sales [Member]                            
Shipping and handling fees                     119,000 109,000 62,000  
Selling Expenses [Member]                            
Shipping and handling fees                     $ 337,000 142,000 87,000  
Patents [Member]                            
Intangible assets estimated useful lives                     17 years      
Finite lived intangible assets, net     719,136       604,916       $ 719,136 604,916    
Amortization expense                     $ 110,000 94,000 150,000  
BoneScapel Generators [Member]                            
Estimated useful lives                     P5Y      
Sonic OneOR Generators [Member]                            
Estimated useful lives                     P5Y      
Minimum [Member]                            
Estimated useful lives                     P3Y      
Maximum [Member]                            
Estimated useful lives                     P5Y      
International [Member]                            
Sales from continuing operations                     $ 10,809,192 10,026,388 11,406,658  
Accounts receivable     860,000       768,000       860,000 768,000    
SonaCare Medical ("SonaCare") [Member]                            
Proceeds from sale of intangible assets $ 5,800,000                   1,504,788      
Earn-out percentage 7.00%                          
Proceeds from sale of intangible assets $ 3,000,000                          
Earn-out percentage 5.00%                          
Proceeds from sale of intangible assets $ 5,800,000                          
Annual Royalty $ 250,000                          
Cicel (Beijing) Science and Tech Co. Ltd. ("Cicel") [Member]                            
Sales from continuing operations                     46,722 1,557,132 2,974,086  
Medtronic Minimally Invasive Therapies ("MMIT") [Member]                            
Accounts receivable     $ 925,000       $ 973,000       925,000 973,000    
Medtronic Minimally Invasive Therapies ("MMIT") [Member] | License Agreement [Member]                            
Royalty revenue                     $ 3,764,000 $ 3,903,000 $ 4,162,000  
Agreement expiration date                     2017-08      
Subsequent Event [Member]                            
Deferred tax asset                           $ 2,500,000